News & Articles
Selected Filters:
SYGNIS AG Launches TruePrime Apoptotic Cell-Free DNA Amplification Kit for the Liquid Biopsy Market
TruePrimE cfDNA kit promises superior selectivity and preferential amplification
Delighting Customers is the Key to Seal of Quality Success for Family Run Company
Find out the secret to Wyatt Technology Corp.’s success as the company celebrates a Gold Seal of Quality for the DAWN HELEOS II
The Road to Precision Medicine Begins with Simple, Robust Methods
Dr. Michael Bianchi, senior lab manager at Empire Genomics explains the fundamental basis of a successful experiment – a protocol that works well.
Free Webinar - Comparative Analysis of FFPE-Derived RNA: A Novel Relationship Between RNA Quality and Sequencing Results
Learn how to optimize FFPE sample preparations to enable successful downstream assays
New Aurora Advanced Flow Cytometry System from Cytek Biosciences Resonates with Researchers Around the World
Systems purchased by laboratories on four continents - and counting
Engineers 3-D Print a “Living Tattoo”
New technique 3-D prints programmed cells into living devices for first time
Neuroscience 2017 Highlights – Meeting the World’s Brightest Scientific Minds
Discover the latest releases, the hottest topics and the stand-out products of the 47th annual society for neuroscience meeting
SpeeDx Prepare for US Launch of ResistancePlus™ MG
Meet Danielle, Neuroscientist and SelectScience Reviewer of the Month for December
Danielle Tomasello describes an average day, her hopes for science in the future and favorite piece of laboratory equipment
Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy
QXDx BCR-ABL %IS kit achieves highest sensitivity for detecting disease remission in patients with chronic myeloid leukemia
Beating Cystic Fibrosis – Perfecting an Intestinal Assay in the Hunt for New Gene Modulators
Learn how a lab in the US has perfected a high-throughput assay in mouse organoids for testing potential new cystic fibrosis drugs
Brain Map Sheds Light on Why Smokers Might Develop Habit
Smokers may be predisposed to their habit because of the molecular make-up of their brain, research suggests.
Ultra-Sensitive Digital Method Detects Rarest of Genome Mutations
Dr. Bruce Conklin, UCSF, discusses the potential of genome engineering as a therapy for genetic diseases
Unlocking the Puzzle of Neurodegenerative Diseases
Unlocking the Potential of <i>C. elegans</i> for the Study of Rare Disease
Dr. Andy Golden, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), explores the value of C. elegans as an animal model for research
DuPont Establishes Microbiome Venture to Lead Development of New Microbiome Science-Based Solutions
DuPont Nutrition & Health partners with APC Microbiome Institute
Third Deal for AMR Centre Puts Focus on Peptides
AMR Centre are taking on an early stage programme with EligoChem to combat antimicrobial resistance
ZEISS VELVET 360-degree Projectors for Vienna Planetarium
360-degree video system by ZEISS will offer new learning opportunities at the planetarium
First Assay to Quantitatively Measure Drug-Kinase Interactions in Live Cells
Promega launches NanoBRET™ target engagement intracellular kinase assay
Washington University Researchers Show Biovica's DiviTum Can Evaluate Ibrance Efficacy After Just Two Weeks Biovica's
New biomarker evaluates the biologic activity of blockbuster breast cancer drug Ibrance
New Deal Could Bring First Treatment for Rare Terminal Disorder in Children
University of Manchester and Orchard Therapeutics team up to treat Sanfilippo syndrome
Science to Save Halloumi Cheese
Scottish scientists have joined a Europe-wide bid to secure the future supply of Cyprus' finest food export - halloumi cheese.
Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Phase II Respiratory Disease Clinical Trial
Trial will analyze breath biomarkers to improve understanding of the treatment effects of a novel GSK pipeline drug candidate for COPD